Press Release (ePRNews.com) - Jan 21, 2016 - Diabetes Tools has been nominated for Best Mobile Innovation for Health in the GSMA’s 2016 Global Mobile Awards for its TriabetesClinic online decision support service that puts medical apps at the heart of diabetes treatment for insulin-dependent children, both in hospital and remotely at home.
“TriabetesClinic for Children combines mobile apps for patient self-care and on-ward mobility with online tools to simplify and digitally rearrange the care around each child with diabetes,” said Diabetes Tools’ Chief Executive Officer Anders Weilandt. “To be chosen by the Glomo Awards judging committee shows that the digital health sector is gaining ground. However, digital health still has a long way to go. This nomination energizes our team’s already considerable persistence and dedication to go the distance.”
“Congratulations to all of the nominees for the 2016 Glomo Awards,” said Michael O’Hara, Chief Marketing Officer, GSMA. “With more than 930 entries this year – a new record – the competition is greater than ever, reflecting the tremendous diversity and pace of innovation across the mobile world. We are particularly excited to be celebrating the 21st year of the awards with a dynamic new format that will recognise and honour achievement throughout Mobile World Congress.”
The Glomo Awards highlight achievements and innovations across the mobile industry and include more than 40 awards in eight categories. The 2016 winners will be announced during Mobile World Congress, the world’s largest mobile industry exhibition and conference, in Barcelona, Spain (22-25 February). For more information, visit http://www.globalmobileawards.com/nominees2016/.
Triabetes and TriabetesClinic are registered trademarks of Diabetes Tools Sweden AB.
About Diabetes Tools
Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better.
Diabetes Tools was named “MedTech Company of the Year 2014” by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden. For more information, visit http://www.diabetestools.se. Source :
Diabetes Tools Sweden AB